Acquired an additional 34% stake in Vizag Hospital & Cancer Research Centre (MG Hospital) for ₹154.50 crore, taking total holding to 85%. MG Hospital generates approximately ₹30 crore per quarter at a 35% EBITDA margin, and the combined Vizag footprint now commands roughly 46% oncology market share in the city. Management has guided for 50%+ Vizag market share and plans to add 60–90 beds across both Vizag facilities over 2–3 years, targeting 1,000+ beds and 10+ LINACs across tier-2 cities over five years. (BSE filing, 13 Apr)

NCLT ordered a shareholder meeting to consider amalgamation with Triumph Offshore Private Limited — consolidating maritime and defence capabilities under a single entity. The NCLT order marks formal regulatory progression; shareholders will vote on scheme terms at the convened meeting. (BSE filing, 13 Apr)

Signed MoUs with HUDCO for urban redevelopment projects and funding collaboration, adding financial pipeline visibility to a consolidated order book of ₹1.27 lakh crore. NBCC secured ₹13,400 crore in new orders in 9M FY26, but management has flagged order-to-execution conversion as the "main focus" for FY26-27, calling it a potential "breakthrough" year. (BSE filing, 13 Apr)

Secured a USD 36.38 million (~₹302 crore) infrastructure equipment order from a Middle East client. In Q3 FY26, management had explicitly stated BEML was "banking on export orders from the GCC/Middle East" and tracking €2,000 crore in export opportunities across Defence, Rail & Metro, and Mining segments. This win validates the export diversification strategy. (BSE filing, 13 Apr)

Received a ₹519.33 crore railway infrastructure order from Mirzapur Thermal Energy (Uttar Pradesh), to be executed over 18 months. The order represents approximately 14% of current market cap and adds to an existing order book of ₹13,624 crore. Management has guided FY27 execution of ~₹7,000 crore, with a fresh order inflow target of ₹10,000–12,000 crore for FY26-27. (BSE filing, 13 Apr)

Completed allotment of 67.43 million equity shares at ₹370.75 per share via QIP, raising approximately ₹2,500 crore. The fundraise deepens capital adequacy (CAR: 18.17%) for an NBFC whose AUM grew 77.6% YoY to ₹55,017 crore as of Q3 FY26, with GNPA improving to 1.51% — the third consecutive quarterly improvement. Management maintained its 35–40% AUM growth guidance for FY26. (BSE filing, 13 Apr)

CARE Ratings upgraded Punjab & Sind Bank from AA− to AA (Stable), reflecting a sustained improvement in asset quality. Gross NPA fell to 2.60% in Dec'25 from 3.83% a year earlier (−123 bps YoY), while Net NPA reached 0.74% — below the bank's own guidance of <0.75%, achieved one quarter ahead of schedule. Provision Coverage Ratio stood at 92.23%. The bank is also planning a ₹3,000 crore QIP during FY26-FY27 to support continued growth. (BSE filing, 13 Apr)

CRISIL reaffirmed TVS Holdings' long-term rating at AA+/Stable — the highest investment-grade notch below AAA. The reaffirmation reflects the continued strength of the TVS Group holding company's financial profile across its motor, financial services, and industrial interests. (BSE filing, 13 Apr)

Nadir Godrej retired as Chairperson and Burjis N. Godrej resigned as Managing Director, both effective April 13, 2026 — with Vishal Sharma (currently CEO, Godrej Chemicals) appointed Chairperson and Arijit Mukherjee (existing COO) elevated to Executive Director. The changes at Astec are the first public step in the Godrej Group's broader succession plan: Nadir is set to retire as Chairman & MD of Godrej Industries Group in August 2026 (upon turning 75), with Pirojsha Godrej taking over as Group Chairperson from August 14. Professional management from within the group ecosystem ensures continuity at Astec. (BSE filing, 13 Apr)